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Abstract
The oxidation of PTH(1-34) catalyzed by ferrous ethylenediaminetetraacetic acid (EDTA) is site-
specific. The oxidation of PTH(1-34) is localized primarily to the residues Met[8] and His[9].
Beyond the transformation of Met[8] and His[9] into methionine sulfoxide and 2-oxo-histidine,
respectively, we observed a hydrolytic cleavage between Met[8] and His[9]. This hydrolysis
requires the presence of FeII and oxygen and can be prevented by diethylenetriaminepentaacetic
acid (DTPA) and phosphate buffer. Conditions leading to this site-specific hydrolysis also
promote the transformation of Met[8] into homocysteine, indicating that the hydrolysis and
transformation of homocysteine may proceed through a common intermediate.
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Protein oxidation is frequently observed in biological aging1–3 and represents a common
problem limiting the stability of protein formulations.4 Frequently, the mechanisms leading
to protein oxidation in pharmaceutical formulations are not well understood due to the
manifold of possible reactions and the potential for varying degrees of protein and/or
excipient impurities to influence reactions pathways. Specific oxidants can react selectively
with individual amino acids and form specific oxidation products depending on the reaction
conditions (i.e., the nature of the formulation). A classic example is the reaction of hydrogen
peroxide, which predominantly oxidizes Met to Met sulfoxide;5–8 however, in the presence
of transition metals, hydrogen peroxide can be converted to hydroxyl radicals through the
Fenton reaction.9 In contrast to hydrogen peroxide, hydroxyl radicals react with all amino
acids.10 Frequently, protein formulations are contaminated by transition metals introduced
through buffers, protein, and excipients or leaching from the metal container. When proteins
contain binding sites for such transition metals, transition metal-catalyzed oxidation
reactions can occur site-specifically, where the respective target sites for oxidation on a
protein are defined by the location of the metal-binding sites. An important example is the
oxidation of His residues and/or amino acids (e.g., Met) in close vicinity to His residues,
which constitute binding sites for transition metals.11–13 Here, the binding of the catalytic
metal to His directs the oxidation toward amino acid targets in protein domains, which
would not necessarily be targeted for oxidation based on solvent-accessible surface area. For
example, the metal-catalyzed oxidation of human relaxin resulted in the oxidation of His and
Met.14 Among two Met residues, Met(B4) was oxidized to a higher extent than Met(B25),
rationalized by the presence of metal-binding residues in the vicinity of Met(B4). In
contrast, the exposure to human relaxin to hydrogen peroxide alone resulted in the opposite
preference, a higher oxidation sensitivity of Met(B25). It was also demonstrated that, during
the preparation of a recombinant humanized monoclonal antibody fragment in the presence
of polysorbate 20, metal-binding to His[31] (in the Fab region) mediated the oxidation of
Trp[50].15
The mechanisms of metal-catalyzed oxidation are complex, involving a manifold of
potential short-lived intermediates such as freely diffusible and/or metal-bound hydroxyl
radicals as well as metal-bound peroxides. Importantly, the extent to which these
intermediates may be responsible for protein oxidation may vary from protein to protein
based on protein conformation and the geometries of the metal-binding sites. In addition, the
nature of the redox-active metal will define the actual oxidation mechanism. Based on
product and kinetic isotope effects, the metal-catalyzed oxidation of human growth hormone
by CuII/ascorbate likely involves hydroxyl radicals (HO•).12 In contrast, scavenger studies
during the oxidation of small Met-containing peptides by the classic Fenton system,
[FeII(EDTA)]2–/H2O2, are more consistent with a “complexed” or metal-bound hydroxyl
radical.16
2. MATERIALS AND METHODS
2.1. Materials
Human parathyroid hormone (1-34) (PTH(1-34))
(SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF, mol wt: 4117.72 Da, Figure 1)
was supplied by American Peptide Co. Inc. (Sunnyvale, CA, USA). The PTH(1-34)
Met[8]Ala mutant was synthesized at Genentech (South San Francisco, CA, USA).
Ammonium acetate (AAc), sodium phosphate (NaH2PO4), iron(II) sulfate heptahydrate
(FeSO4 × 7H2O), iron(III) sulfate hydrate (Fe2(SO4)3 × H2O), ethylenediaminetetraacetic
acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), N-ethylmaleimide (NEM), and
catalase from bovine liver were supplied by Sigma-Aldrich (St. Louis, MO, USA) at the
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highest purity grade. Hydrogen peroxide (H2O2, 30%) was supplied by Fisher Scientific
(Pittsburgh, PA, USA). Sequencing trypsin grade was supplied by Promega (Madison, WI,
USA). To ensure that our solutions were not contaminated by any protease, some control
experiments were performed according to the experimental protocols 1 and 5 (see below
Section 2.3) in the presence of protease inhibitors (cOmplete ULTRA Tablets, Roche,
Indianapolis, IN, USA). In addition, to probe for potential bacterial contamination, a series
of control experiments was performed with solutions which had been subjected to sterile
filtration, using a sterile syringe filter equipped with a 0.2 μm membrane (Corning
Incorporated, New York, NY, USA) and used in a sterile room.
2.2. Digestion of PTH(1-34) and PTH(1-34) Met[8]Ala
PTH(1-34) and PTH(1-34) Met[8]Ala were digested with trypsin (1 μg/mL) in ammonium
bicarbonate buffer (50 mM, pH 8.0) at 37 °C for 3 h. The digestion was either performed
under air or Ar. This experimental parameter is given in Section 2.3 along with the
description of the different protocols for the oxidation of PTH(1-34) and its mutant.
The proteolytic cleavage sites are presented in Figure 1. Fragments F1–F4 indicate the
location of tryptic peptides shared by PTH(1-34) and PTH(1-34) Met[8]Ala, which are
rather insensitive to chemical modification by the Fenton reaction. Fragments F5 and F5A
indicate the location of the N-terminal tryptic fragments of PTH(1-34) and PTH(1-34)
Met[8]Ala, respectively, which are the predominant target sites for modification by the
Fenton reaction. Although PTH is not very hydrophobic and could have been analyzed as an
intact protein by high-performance liquid chromatography, we preferred to tryptic digest
PTH. The possible formation of cross-links during the metal-catalyzed oxidation of PTH
may generate high molecular weight products. Indeed, the oxidation of Tyr and Phe residues
can mediate the formation of cross-links with amino groups through Michael addition.17
2.3. Oxidation of PTH(1-34) by the Fenton Reaction
PTH(1-34) was oxidized according to different protocols, referred to as Exp.1–Exp.10,
schematically displayed in Figure 2. The stock solutions of FeII/EDTA, FeII/DTPA, and
H2O2 were prepared at a concentration of 10 mM in ammonium acetate buffer (20 mM, pH
6.9). The stock solution of DTPA was prepared at a concentration of 1 mM in ammonium
acetate buffer (20 mM, pH 6.9). PTH(1-34) and catalase were prepared at a concentration of
24.3 μM (0.1 mg/mL) and 1.4 μM, respectively, in ammonium acetate buffer (20 mM, pH
6.9). The stock solutions of FeII/EDTA, FeII/DTPA, H2O2, and PTH(1-34) were always
prepared and kept under Ar. Subsequently, the incubation of the reaction mixtures was
performed either under air (Exp. 1–4 and 8) or under Ar (Exp. 5–7). After 15 min reaction
time, 25 μL of catalase (1.4 μM) were added to the final solution to remove H2O2. When
applicable, digestions were performed in the presence of air, according to the protocol
described in Section 2.2.
2.3.1. Protocol Exp. 1 (Figure 2a)—Samples of 10 μL each of FeII/EDTA and H2O2
were mixed under Ar with 980 μL of PTH(1-34) to yield initial molar ratios of
[FeII(EDTA)]2–/H2O2/ PTH(1-34) = 1:1:0.24 (it is important to note that not all oxidants
generated through reactions 1–4 will be available to react with PTH(1-34) as these oxidants
also readily react with [FeII(EDTA)]2–).18 The reaction vial was opened to air, and after 30
min of incubation at 37 °C under air, 250 μL of the reaction sample were diluted with 250
μL of DTPA (1 mM) (the use of DTPA serves to terminate a hydrolysis reaction which will
be confirmed in Exp. 2 below). Digestion was performed according to the protocol given in
Section 2.2.
Mozziconacci et al. Page 3













2.3.2. Protocol Exp. 2 (Figure 2a)—Sample of 10 μL each of FeII/DTPA and H2O2
were mixed with 980 μL of PTH(1-34). After 30 min of incubation at 37 °C under air, 250
μL of the reaction sample was diluted with 250 μL of DTPA (1 mM). Digestion was
performed according to the protocol given in Section 2.2.
2.3.3. Protocol Exp. 3 (Figure 2a)—Samples of 10 μL each of FeII/EDTA and H2O2
were mixed under Ar with 980 μL of PTH(1-34). After 30 min of incubation at 37 °C under
air, 250 μL of the reaction sample was diluted with 250 μL of ammonium acetate buffer (20
mM, pH 6.9). In contrast to the protocols of Exp. 1 and Exp. 2, the hydrolysis reaction was
not terminated through the addition of DTPA.
2.3.4. Protocol Exp. 4 (Figure 2a)—Samples of 10 μL each of FeII/EDTA and 10 μL of
water were mixed with 980 μL of PTH(1-34). In contrast to Exp. 1 and 2, no H2O2 was
added to the reaction sample. After 30 min of incubation at 37 °C under air, 250 μL of the
reaction sample was diluted with 250 μL of DTPA (1 mM). Digestion was performed
according to the protocol given in Section 2.2.
2.3.5. Protocol Exp. 5 (Figure 2b)—Samples of 10 μL each of FeII/EDTA and H2O2
were mixed with 980 μL of PTH(1-34). After 30 min of incubation at 37 °C under Ar, 250
μL of the reaction sample was mixed, under Ar, with 250 μL of ammonium acetate buffer
(20 mM, pH 6.9). The reaction was also run at pH 7.9 and 4.5. The pH of the buffers was
adjusted to the new values by using 1 M NaOH or 1 M HCl. Digestion was performed
according to the protocol given in Section 2.2.
2.3.6. Protocol Exp. 6 (Figure 2b)—Samples of μL each of FeII/EDTA and H2O2 were
mixed with 980 μL of PTH(1-34). After 30 min of incubation at 37 °C under Ar, 250 μL of
the sample was combined with 250 μL of DTPA (1 mM) under Ar. After 15 min, 25 μL of
catalase (1.4 μM) was added to the final solution (kept under Ar) prior to digestion. The
digestion was performed under Ar according to the protocol described in Section 2.2.
2.3.7. Protocol Exp. 7: Oxidation in the Absence of Metal—Samples of 10 μL each
of DTPA and H2O2 were mixed with 980 μL of PTH(1-34). After 30 min of incubation at
37 °C under Ar, 25 μL of catalase (1.4 μM) were added to the final solution (kept under Ar)
prior to digestion. The digestion was performed under Ar according to the protocol
described in Section 2.2.
2.3.8. Protocol Exp. 8: Replacement of [FeII(EDTA)]2– by [FeIII(EDTA)]–—
Samples of 10 μL each of FeIII/EDTA and H2O2 were mixed with 980 μL of PTH(1-34).
After 30 min of incubation at 37 °C under Ar, 25 μL of catalase (1.4 μM) were added to the
final solution (kept under Ar) prior to digestion. The digestion was performed under Ar
according to the protocol described in Section 2.2.
2.3.9. Protocol Exp. 9: Oxidation in the Presence of FeII and Absence of EDTA
and H2O2—A FeCl2 stock solution (10 mM) was prepared in ammonium acetate buffer
(pH 6.9). The buffer was Ar-saturated before the addition of FeII. A sample of 10 μL of this
solution was mixed with 990 μL of PTH(1-34). After 30 min of incubation at 37 °C under
Ar, the solution was opened to air. No catalase was added to the final solution prior to
digestion. The digestion was performed under air.
2.3.10. Protocol Exp. 10: Oxidation in the Presence of H2O18—For this
experimental protocol, 10 μL each of FeII/EDTA and H2O2 of which the stock solutions
were prepared in H2O16, were mixed with 980 μL of PTH(1-34) prepared in H2O18. After
Mozziconacci et al. Page 4













30 min of incubation at 37 °C under air, 250 μL of the reaction sample were diluted with
250 μL of DTPA (1 mM). After 15 min, 25 μL of catalase (1.4 μM) were added to the final
solution. This sample was not digested.
2.3.11. Detection of Homocysteine—PTH(1-34) was oxidized according to the
experimental protocols Exp. 1 (Section 2.3.1) and Exp. 9 (Section 2.3.9). After oxidation,
NEM (1 mM) was added to the sample. The pH of the solution was adjusted to 8.0 by the
addition of NaOH. After incubation at 37 °C for 30 min, β-mercaptoethanol (10 mM) was
added to the solution prior to the start of the digestion. The digestion was performed
according to the protocol described in Section 2.1. NEM served to alkylate the thiol group of
the homocysteine residue.
2.4. Sample Preparation for Capillary LC-MS Analysis
LC-MS analyses of the reaction mixtures (prepared according to the protocols Exp.1–10)
were performed on a Capillary Liquid Chromatography System (Waters Corporation,
Milford, MA, USA). Samples of 10 μL of each sample were injected onto a C18 Vydac
column (25 cm × 0.5 mm, 3.5 μm) and eluted with a linear gradient delivered at the rate of
20 μL/min. Mobile phases consisted of water/acetonitrile/formic acid at a ratio of 99%, 1%,
and 0.08% (v:v:v) for solvent A and a ratio of 1%, 99%, and 0.06% (v:v:v) for solvent B.
The following linear gradient was set: 10–50% of solvent B within 30 min.
2.5. Nano-Electrospray Ionization Time-of-Flight MS (ESI-TOF-MS) Analysis
ESI-MS spectra of undigested PTH(1-34) and of the peptide digests were acquired on a
SYNAPT-G2 (Waters Corp., Milford, MA). The SYNAPT-G2 instrument was operated for
maximum resolution with all lenses optimized on the [M + 2H]2+ ion from the [Glu]1-
fibrinopeptide B. The cone voltage was 45 V, and Ar was admitted to the collision cell. The
spectra were acquired using a mass range of 50–2000 amu (= atomic mass unit). The data
were accumulated for 0.7 s per cycle.
2.6. MS/MS Analysis
The proteolytic digest of PTH(1-34) was analyzed either by means of a SYNAPT-G2
(Waters Corp., Milford, MA, USA) or an LTQ-FT mass spectrometer (Thermo Finnigan,
West Palm Beach, FL, USA) under conditions described elsewhere. 19 On the SYNAPT-G2,
MS/MS spectra were acquired by setting the MS1 quadrupole to transmit a precursor mass
window of ±0.1 amu. The MS/MS spectra were analyzed with the software MassMatrix20–23
and ProteinLynx Global Server from Waters Corp. (Milford, MA, USA). On the LTQ-FT
mass spectrometer, peptides were separated on a reverse-phase LC Packings PepMap C18
column (0.300 × 150 mm) at a flow rate of 10 μL/min with a linear gradient rising from 0 to
65% acetonitrile in 0.06% aqueous formic acid over a period of 55 min using LC Packing
Ultimate Chromatograph (Dionex). LC-MS experiments were performed in a data-
dependent acquisition manner using the Xcalibur 2.0 software (Thermo Scientific West
Palm Beach, FL, USA). The five most intensive precursor ions in a survey MS1 mass
spectrum acquired in the Fourier transform-ion cyclotron resonance over a mass range of
300–2000 m/z were selected and fragmented in the linear ion trap by collision-induced
dissociation. The ion selection threshold was 500 counts. For both instruments, the
theoretical fragments were compared to the experimental MS/MS spectra to validate the
structures of the products. The structures were validated only if the differences between the
theoretical and the experimental m/z of the parent ion (and the fragment ions) were strictly
below 0.1 Da.
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The MS/MS spectra of the unmodified tryptic fragments of a PTH(1-34) control are
presented in Figure S1–S5 (Supporting Information). The experimental protocols (Exp. 1–
10) are summarized in Figure 2. A list of the sequences of the tryptic fragments of
PTH(1-34), PTH(1-34) Met[8]Ala) and of some oxidation products are presented in Table 1.
The results are succinctly summarized in Table 2. The relative quantification of the
oxidation products was obtained by (i) calculation of the peak area for each product from the
LC-MS chromatograms (total ion counts, TIC) and (ii) the calculation of the ratio: area of
the peak of interest/sum of the peak areas.
3.1. Nature of Oxidation Products of PTH(1-34)
Prior to the complete description of the LC-MS chromatograms obtained after oxidation of
PTH(1-34), we shall present here an overview over the different products of oxidation.
The Fenton oxidation of PTH(1-34) under air and Ar leads to the formation of three major
products, P1, P2, and P3 (Table 1). These products are fully characterized by their CID
spectra presented in Figures 4, 5, and S6.
Product P1—P1 (m/z 1471.2) is the result of the oxidation of Met[8] to Met sulfoxide
(MetSO). Formation of MetSO at position 8 is confirmed by MS/MS sequencing of P1
(Figure 4). The y and b fragment ions fully characterize the sequence. In particular, the y5
(m/z 568.3) and y6 (m/z 615.4) fragments demonstrate the addition of +16 Da on Met[8]
(Figure 4), and the peaks with m/z 651.36 and m/z 764.45 are derived from the neutral loss
of 64 Da (CH3SOH) from y6 and y7, respectively. The neutral loss of CH3SOH is also
observed for y8 (m/z 892.5) and y9 (m/z 1005.59).
Product P2—P2 (m/z 906.4) results from the hydrolysis of the peptide bond between
residues Met[8] and His[9] (Table 1). The MS/MS sequencing of P2 is presented in Figure
5. The presence of the y1 fragment ion clearly demonstrates that Met[8] represents the C-
terminal residue of P2.
Product P3—P3 (m/z 1487.3) is the result of the oxidation of the residues Met[8] and
His[9] to MetSO and 2-oxo-histidine,24 respectively (Table 1). The MS/MS sequencing of
P3 is presented in the Supporting Information (Figure S6). The fragment ions y4 (m/z 431.3)
and y6 (m/z 731.4) and the presence of b8 (m/z 904.4) demonstrate the incorporation of one
oxygen into each residue, Met[8] and His[9]. The oxidation of PTH(1-34) by H2O2 under air
leads to the formation of two major products, P1 and P3. Product P1 has been described
above.
Product P4—In product P4, Met[8] is replaced by homocysteine. The characterization and
mechanism of formation of P4 is described in more detail below (Section 3.12).
Because products P1, P2, and P3 are related to the oxidation of the residues Met[8] or
Met[8] and His[9], which belong to the tryptic fragment F5, the yield of these products will
be given throughout this paper as the relative ratio of conversion of F5 into its respective
products of oxidation, P1, P2, or P3.
Oxidation products of Met[18], Trp[23], and His[32] only formed at trace levels during the
Fenton oxidation of PTH(1-34).
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3.2. Fenton Oxidation of PTH(1-34) under Air: Exp. 1–4
I. Oxidation in the Presence of FeII/EDTA. In the Presence of H2O2 (Exp. 1 and
3)—The oxidation of PTH(1-34) by FeII/EDTA and H2O2 (Exp. 1 and 3, Figure 2) shows
the same LC-MS profile (Figure 6B,D) independent of the addition of DTPA prior to the
addition of catalase. Oxidation of PTH(1-34) under such conditions results in the formation
of P1 and P2 (monitored after proteolytic digestion). In fact, the ratios of P1/F5 and P2/F5
are equal to 82% and 12% without the addition of DTPA and 83% and 11% with the
addition of DTPA (Figure 3). Under these experimental conditions, the addition of DTPA
after 30 min reaction time had no effect on the product yields of P1 and P2 since both
reactions were complete prior to the addition of DTPA. As the samples were exposed to air
prior to the addition of DTPA, the formation of P2 likely occurred during air-exposure (see
also below). Product P2 was also observed by MS analysis when PTH(1-34) was not
digested after Fenton oxidation. This demonstrates that the hydrolytic cleavage observed
between Met[8] and His[9] did not occur during proteolytic digestion.
In the Absence of H2O2 (Exp. 4)—The exposure of PTH(1-34) to FeII/EDTA in the
absence of H2O2 led to a significant decrease of the yield of P1, while the yield of product
P2 shows a significant increase (Figure 3; Figure 6B vs E). In the absence of H2O2, only 4%
of Met[8] was oxidized to MetSO, as characterized by the ratio P1/F5 (Figure 3, Exp. 4). In
contrast, the ratio P2/ F5 reached 33% (Figure 3, Exp. 4), indicating that higher yields of P2
was formed in the absence of H2O2.
Oxidation Using FeII/DTPA (Exp. 2)—The LC-MS profile of the oxidation of
PTH(1-34) by FeII/DTPA in the presence of H2O2 (Exp. 2, Figure 2) reveals only the
formation of P1 (Figure 6C), while product P2 is not formed. The ratio P1/F5 reached 23%
under these conditions (Figure 3). We can conclude that the addition of DTPA prevented the
formation of P2 and decreased the yield of oxidation of Met[8], that is, the conversion of F5
into P1.
3.3. Oxidation of PTH(1-34) under Ar: Exp. 5 and 6
PTH(1-34) was oxidized in the presence of FeII/EDTA and H2O2. All of the samples were
maintained under Ar, from the preparation of the stock solutions until the end of the
proteolytic digestion.
In the Absence of DTPA (Exp. 5)—After oxidation of PTH(1-34), no DTPA was added
to the solution prior to digestion, and the reaction mixture was exposed to air only prior to
LC-MS analysis (Figure 2). LC-MS analysis shows the formation of products P1 and P2
with a relative yield of 12% (P1/F5) and 34% (P2/F5), respectively (Figure 7A and Figure
3).
Variation of the pH (Exp. 5)—The pH was changed to 7.9 and 4.5 by the addition of
NaOH or HCl, respectively, to the solution. At pH 7.9, no significant changes were observed
compared to pH 6.9. Under acidic condition, pH 4.5, product P2 was not observed. The
yield P1/F5 was 100% (Figure S7).
In the Presence of DTPA (Exp. 6)—Immediately after the oxidation of PTH(1-34),
DTPA was added to the solution while still under Ar. The comparison of the LC-MS data
(Figure 7A and B) demonstrates that the hydrolytic cleavage leading to the formation of P2
does not occur during LC-MS analysis. After proteolytic digestion, LC-MS analysis
revealed only the formation of product P1 with a relative yield (P1/F5) of 10% (Figure 7B
and Figure 3).
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The data demonstrate that the formation of P2 requires O2 (Exp. 1 vs 5) and FeII/EDTA
(Exp. 1 vs 2) but does not require H2O2 (Exp. 4) and can be prevented by DTPA (Exp. 4 vs
3). The two experiments described above (Section 3.3) vary only in the addition of DTPA
prior to digestion (under air). It appears that, even after 30 min reaction time under Ar, some
[FeII/EDTA]2– is left in the solution, which upon exposure to air (for digestion) promotes
the hydrolysis between Met[8] and His[9]. To convert residual [FeII/EDTA]2– to some
[FeIII/EDTA]– under Ar, we first incubated PTH(1-34) according to experimental protocol
Exp. 5 and subsequently added an excess of H2O2 (50 mM) under Ar, prior to exposing the
solution to air. No DTPA was added. LC-MS analysis reveals that under these conditions the
tryptic peptide F5 was completely converted into P1. Product P2 was not observed (Figure
8A; control, Figure 8B, is displayed to localize the peak corresponding to F5). The result of
this experiment supports the observations emphasized in Exp. 1 vs 5 and Exp. 1 vs 2 that the
formation of P2 requires the presence of molecular oxygen and FeII. Hence, EDTA is not
necessary for the formation of P2 (see Section 3.7).
3.4. Oxidation of PTH(1-34) in the Presence of DTPA and H2O2 but Absence of FeII
PTH(1-34) was oxidized according to the protocol Exp. 7. The LC-MS analysis presented in
Figure 9 shows that the tryptic fragment F5 was completely transformed into product P1.
Under these conditions of oxidation, 100% of Met[8] was therefore converted into MetSO.
Product P2 was not formed.
3.5. Oxidation of PTH(1-34) Using FeIII
Following the experimental protocol Exp. 8, product P2 was not formed if PTH(1-34) was
incubated at 37 °C for 30 min in the presence of [FeIII/EDTA]– and H2O2, either under Ar or
air (LC-MS analysis was similar to the one obtained after oxidation of PTH(1-34) in
phosphate buffer, see Figure S8A). Product P1 was formed. The relative yield of conversion
P1/F5 was 13%.
3.6. Oxidation of PTH(1-34) in Phosphate Buffer
The experimental protocol Exp. 1 (Section 2.3.1) was modified to replace ammonium
acetate buffer with potassium phosphate buffer. In potassium phosphate buffer, the oxidation
of PTH(1-34) in the presence of FeII/EDTA and H2O2 did not yield P2 (Figure S8A).
Product P1 was observed with a relative yield P1/F5 = 12%.
3.7. Oxidation of PTH(1-34) Using FeII without EDTA and H2O2
PTH(1-34) was oxidized according to the experimental protocol Exp. 9. After incubation of
PTH(1-34) in the presence of only FeII in Ar at 37 °C, the solution was exposed to air. After
digestion, LC-MS analysis revealed the formation of P2 with a relative yield P2/F5 = 13%.
P1 was observed with a relative yield P1/F5 = 5% (Figure S9).
3.8. Oxidation of PTH(1-34) in the Presence of Added Methionine
PTH(1-34) was oxidized according to the protocol of Exp. 1 (Section 2.3.1), except that
methionine (1 mM) was added to the solution prior to incubation. The exogenous
methionine prevented the formation of P2 (relative yield P2/F5 < 0.5%).
3.9. Preoxidation of PTH(1-34) by H2O2, Followed by Fenton Oxidation
PTH(1-34) was preoxidized with H2O2 under air prior to Fenton oxidation according to the
experimental protocol Exp. 1. A representative LC-MS analysis of such preoxidized
PTH(1-34) is presented in Figure 10. After proteolytic digestion, in addition to the
unmodified tryptic fragments (F2–F4), LC-MS analysis reveals the presence of products P1
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and P3 (Table 1). The absence of the tryptic fragment F5 demonstrates the conversion of
Met[8] and His[9] into MetSO (P1) and 2-oxo-His (P3). The ratio P3/P1 = 50% indicates
that 66% of F5 is converted into P1 (ratio P1/F5) and 33% into P3 (ratio P3/F5)
(considering that the total amount of F5 is converted into P1 and P3, F5 = P1 + P3). After
Fenton oxidation, no significant other products are observed. In particular, the absence of P2
suggests that neither P1 nor P3 is a suitable precursor for P2.
3.10. Oxidation of PTH(1-34) Met[8]Ala under Air
PTH(1-34) Met[8]Ala was oxidized according to the experimental protocol Exp. 1 (Section
2.3.1). A comparison of nonoxidized (control) and oxidized PTH(1-34) Met[8]Ala (Figure
11) does not show any significant difference. Hence, the substitution of Met[8] by Ala[8]
prevented the hydrolysis of the peptide bond between Ala[8] and His[9]. If the hydrolysis
between Ala[8] and His[9] had occurred, we would have expected to observe the formation
of product P2A (m/z 846.4, Table 1). The absence of P2A during the Fenton oxidation of
PTH(1-34) Met[8]Ala demonstrates the involvement of Met[8] in the hydrolysis mechanism
during the Fenton oxidation of PTH(1-34).
3.11. Oxidation of PTH(1-34) in H2O18
A mass spectrometry analysis in the range of m/z 906.0–912.0 (Figure 12) reveals that after
Fenton oxidation of PTH(1-34) (protocol Exp. 10) in the presence of H2O18/H2O16 (80:20,
v:v) the ions with m/z 908.4 and m/z 906.4 are present in a 100:83 ratio; that is, close to the
isotopic ratio of O18/O16 in water under these conditions. This result demonstrates a
nucleophilic attack of H2O on an intermediate leading to the hydrolysis product.
3.12. Conversion of Met[8] into Homocysteine
During the Fenton oxidation of PTH(1-34), in the presence of [FeII/EDTA]2– and H2O2, we
observed the transformation of Met[8] into homocysteine. The homocysteine residue was
fully characterized by the MS/MS analysis of product P4 (Figure 13) and P4-NEM (Figure
14), generated by alkylation of P4 with NEM. The structure of P4 is characterized by the
presence of the a7, b8, y5, and y6 fragment ions, which demonstrate the loss of 14 Da from
the Met[8] residue originally present in the tryptic fragment F5 (Figure 13). P4-NEM
contains two NEM groups located at the homocysteine and at C-terminal Lys residues,
respectively. The structure of P4-NEM is characterized by the series of b3–b6, b8, b9, b11,
and b12 fragment ions, and multiple internal fragment ions (e.g., EIQLu1, u1HNLG) (Figure
14). The latter demonstrate that the homocysteine residue (labeled “u1” in the sequence) is
derivatized with NEM. The y1–y3 fragment ions allow the identification of the C-terminal
lysine (labeled “u2” in the sequence) as the second residue derivatized with NEM.
Noteworthy, the conversion of Met[8] into homocysteine was observed along with the
formation of P2. In contrast, when PTH(1-34) was oxidized under conditions where P2 was
not observed, no transformation of Met[8] into homocysteine was observed either. Those
results point to a common intermediate in the formation of the hydrolysis product P2 and the
homocysteine-containing product P4. However, when PTH-(1-34) was oxidized in the
presence of MeOH (1 M) or in the absence of H2O2, only the formation of P2 but not that of
P4 was detected.
4. DISCUSSION
To predict oxidation and stability problems for protein pharmaceuticals, more detailed
mechanistic studies are necessary, which characterize and quantify oxidation products for
specific oxidation pathways as a function of peptide and protein sequence and
conformational properties. Such mechanistic studies are here presented for the Fenton
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oxidation of parathyroid hormone (1-34), PTH(1-34), a suitable model protein, which
contains a number of oxidizable amino acids such as His, Met, Trp, and Tyr. 25 For our
experiments, the individual components of the Fenton reaction, [FeII(EDTA)]2–(EDTA =
ethylenediaminetetraacetate), H2O2, and PTH(1-34) were prepared under Ar to maintain a
set of defined and reproducible reaction conditions. Subsequently, these components were
combined either under Ar or air to assess the influence of O2 on the oxidation yields. These
conditions are different to those of Ji et al.,25 who prepared PTH(1-34), FeCl2 and H2O2
without EDTA under air. The latter conditions do not allow for an appropriate
characterization of the involvement of molecular oxygen in the oxidation mechanisms of
PTH(1-34). Thus, comparative studies under Ar and air are mandatory. Under Ar, the
presence of EDTA allows to start the reaction with a defined complex of FeII, that is,
[FeII(EDTA)]2–, while in the absence of EDTA various complexes of FeII may be present at
the start of the reaction, potentially involving the buffer and multiple binding sites of
PTH(1-34). An additional problem with Ji's preparation is, that in oxygen-containing
solution FeII will convert rapidly into FeIII, so that the actual concentration of FeII at the
time point of H2O2 addition to the solution may be negligible. Instead, in our experiments
we prepared [FeII(EDTA)]2– under Ar, prior to the addition of [FeII(EDTA)] 2– into a
solution containing either O2 or O2 and H2O2 to start the reaction.
For mechanistic purposes, in this study, either selected components of our Fenton system
were omitted (controls) or oxygen was admitted to the reaction mixture after the addition of
[FeII(EDTA)]2– to PTH(1-34) under Ar. These experimental variations led to the
characterization of a complex oxidation mechanism, where the reaction of [FeII(EDTA)]2–/
H2O2 with PTH(1-34) leads to the oxidation of predominantly His and Met, but the
exposure of PTH(1-34) to [FeII(EDTA)]2– and O2 (in the absence of H2O2) resulted in the
specific hydrolysis of the peptide bond between Met-8 and His-9. This hydrolysis reaction is
prevented in a PTH(1-34) mutant, in which Met[8] is replaced by Ala[8], referred to as
PTH(1-34)Met[8]Ala, and by replacement of EDTA with diethylenetriaminepentaacetate
(DTPA). In contrast, the replacement of EDTA by DTPA had no significant effect on the
oxidation yields from Met and His, in accordance with the fact that H2O2 reacts with both
[FeII(EDTA)]2– and [FeII(DTPA)]3–, albeit the rate constant for reaction with
[FeII(EDTA)]2– (reaction 1) is an order of magnitude higher compared to that with
[FeII(DTPA)]3–.18,26 An important difference between the two chelators EDTA and DTPA
is the availability of eight metal-binding coordination sites in DTPA compared with six
coordination sites in EDTA. The crystal structure of [FeII(EDTA)]2– demonstrates that the
central FeII ion is complexed by seven ligands, six EDTA-derived ligands, and one water
molecule,27 which would explain the high reactivity with H2O2. In contrast, DTPA binds to
iron through a heptavalent complex28 that saturates all potentially valencies in
[FeII(DTPA)]3–. Hence, the reaction of H2O2 with [FeII(DTPA)]3– would require the
dissociation of one of the coordinating ligands, rationalizing the faster reaction of H2O2 with
[FeII(EDTA)]2– compared to [FeIII(EDTA)]3–. Here the heptacoordination by DTPA
compared to hexacoordination by EDTA is likely also the reason for the higher stability
constants of the DTPA vs EDTA complexes, where the individual stability constants
log(KML) are given in parentheses: FeII-EDTA (14.33), FeIII-EDTA (25.1), FeII-DTPA
(16.50), FeIII-DTPA (28.6).29,30
The Fenton reaction between FeII and H2O2 involves various intermediates, where H2O2
first adds to FeII, prior to the formation of FeIII and a free hydroxyl radical (reactions 1–4,
representatively shown for [FeII(EDTA)]2–).18,31–33 [FeII(EDTA)]2– is extremely oxygen-
sensitive.28 In the presence of O2, [FeII(EDTA)O2]2– can be converted through an acid-
catalyzed electron-transfer process in [FeIII(EDTA)]– and HO2•(⇄ H+ + O2•–). Here, acidic
conditions lead to the protonation of EDTA in [FeII(EDTA)(H2O)]2– (reaction 5) resulting
into a change of the geometry of the complex. The new complex, [FeII(EDTAH)(H2O)]–, is
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a pentagonalbipyramidal species that can bind more rapidly to O2 than the nonprotonated







The FeII-EDTA intermediates presented in reactions 1–6, as well as the hydroxyl radical,
and [FeIII(EDTA)(OH)]– will react with amino acids of PTH(1-34) to different extents,
depending on the nature of the intermediates. In addition, a possible association of
PTH(1-34) with the initial [FeII(EDTA)]2– complex or some of the intermediates, for
example, [FeII(EDTAH)O2]–, must be considered, potentially localizing the reactive
intermediates to specific sites of PTH(1-34). Such association can be through coordination
of the metal to an appropriate amino acid side chain (e.g., of His). In addition, the
electrostatic interaction of EDTA with His has been documented by 1H NMR studies, for
example, for bovine pancreatic ribonuclease,36 suggesting that overall negatively charged
complexes of FeII and FeIII with EDTA and DTPA may show similar interactions with other
proteins.
PTH(1-34) was easily modified under air in the presence of [FeII/EDTA]2–. These
conditions resulted in a hydrolytic cleavage between Met[8] and His[9], which depended on
the presence of FeII and O2. Importantly, the presence of H2O2 increased the yield of
oxidation of Met[8] into MetSO but lowered the hydrolysis of the peptide bond between
Met[8] and His[9]. In addition, the presence of exogenous Met during the oxidation of
PTH(1-34) or the mutation of Met[8] to Ala[8] prevented the hydrolytic reaction. In addition
to these observations, the oxidation of Met[8] into MetSO prevented the hydrolytic reaction.
These observations suggest that an unmodified sulfur in Met[8] is required to initiate the
formation of an intermediate, which can lead to the hydrolysis of the peptide bond Met[8]–
His[9]. This intermediate is most likely an oxidized sulfur, such as the sulfide radical cation
C2 displayed in Scheme 1. The formation of such an oxidized intermediate is consistent
with the protective role of exogenous Met (competing for the oxidizing species) and also the
formation of product P4 (see Scheme 2). We observed that Met[18], Trp[23], and His[32]
were hardly oxidized under our experimental conditions. Besides, no hydrolytic cleavage
around the residues Met[18] and His[32] was observed. Such observations indicate that the
proximity (in space and in the sequence) of the residues Met and His promotes the
hydrolysis of the peptide bond that links these two residues.
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In the following, we will rationalize our experimental results to explain how molecular
oxygen, FeII, Met[8] and His[9] can interact to drive the cleavage of the peptide bond
between Met[8] and His[9]. Our hypothesis is that the hydrolytic reaction can occur in a
complex involving PTH(1-34) (likely through His[9]) and a peroxo-iron species. The
involvement of His coordination in the formation of P2 is suggested by the observed pH-
dependency, where no formation of P2 was observed at pH 4.5, that is, when the His residue
was protonated. A preliminary discussion about the possible nature of the peroxo-iron
complex is, therefore, mandatory to explain the mechanism leading to the specific
hydrolysis of the peptide bond between Met[8] and His[9].
The Primary Oxidizing Species
Experiments under Ar—The precursors leading to the oxidizing species are presented in
reactions 1–6, where the addition of H2O2 to [FeII/EDTA]2– (reaction 1, k1 = 7–17.5 × 103
M–1 s–1),26 is followed by the elimination of a molecule of HO– or H2O (reactions 2 and
3).18,31–33 Any of these iron-oxo complexes generated through reactions 2 and 6 are able to
react through either electron transfer or hydrogen-atom abstraction with substrates, here
PTH(1-34).18,33,37,38
Experiments under Air—The presence of O2 can change the nature of the intermediates
leading to the primary oxidizing species. The oxidation of aqueous FeII, FeIIaq, can be
written as an O2– and HO–-dependent reaction (reaction 7) with an oxidation rate described
by eq E1 in the pH range 4–8 (in bicarbonate solutions).39
(7)
(E1)
If the oxidation of FeIIaq is only described by reaction 7 (and eq E1), the primary oxidizing
species is HO2•/O2•–, or the dismutation product, H2O2 (reaction 8).
(8)
However, reaction 7 has to be re-evaluated when ferrous iron is chelated. Indeed, the
reaction order on FeIIaq may vary from first to second order. This reaction order dependency
can be related to the pH and concentration of the FeII chelate. In the presence of chelators
such as EDTA, DTPA, and nitrilotriacetate (NTA) there is general agreement that above pH
6 the reaction with O2 is pH-independent.40–43 Zang and van Eldik have determined a
kinetic order of 1 and 1–2 with regard to O2 and FeII, respectively40 under the following
conditions: (i) 25 μM < [FeII] < 20 mM, (ii) 50 μM < [EDTA] < 20 mM, (iii) 125 μM <
[O2] < 1.25 mM, (iv) 2 < pH < 7. The increase of the order of reaction in ferrous chelate
with increasing concentrations of ferrous chelate is explained by reactions 9–13 (where L
represents a chelator).40 A short discussion about the order of the reaction on ferrous iron
and oxygen is warranted if we want to evaluate the degree of oxidation of iron in the
[FeII(EDTA)]2–/O2 complex under our experimental conditions.
(9)
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At the lowest concentration of ferrous chelate (≤100 μM), reaction 8 is likely to be rate-
controlling, while reaction 11 is negligible. An increase of the concentration of ferrous
chelate should promote reaction 11 such that, at some point, it will compete against reaction
10, resulting in a change of the order of the reaction from one to two.
Thus, the rate constant for the oxidation of [FeII(EDTA)]2– by O2 can be estimated to be
either between 20 and 300 M–1 s–1 at pH 6 in the presence of excess oxygen (with a first-
order reaction on [FeII(EDTA)]2–)34,44 or between 6.5 and 18 × 103 M–2 s–1 for a pH range
5–7.5 in the presence of an excess of [FeII(EDTA)]2– (with the reaction being second order
with regard to [FeII(EDTA)]2–).40,45
Importantly, under our conditions of oxidation of PTH(1-34), with [FeII(EDTA)]2– = 100
μM, the major oxidizing species is likely a peroxo-iron complex, as referred to in
equilibrium 14, and illustrated in Scheme 1.
Hydrolysis of the Peptide Bond between Met[8] and His[9]
The hydrolysis of the peptide bond between Met[8] and His[9] requires FeII, O2, and a pH at
which the imidizole nitrogen is deprotonated (P2 was not formed at pH 4.5 in Exp 5),
consistent with the necessity of the imidazole side chain for coordination of FeII. The
hydrolysis proceeds in the presence of EDTA but not DTPA and proceeds in the presence of
acetate but not phosphate. Our results show that the formation of P2 is inhibited through the
oxidation of Met[8] and that H2O2 is not required for hydrolysis (Figures 6B vs D and 8).
The replacement of Met[8] by Ala[8] in the PTH(1-34)Met[8]Ala mutant as well as the
preoxidation of Met[8] into MetSO prevent the hydrolysis of the peptide bond between
Met[8] (or Ala[8]) and His[9] in PTH(1-34) (and the PTH(1-34) Met[8]/Ala mutant). These
results suggest that the hydrolysis between Met[8] and His[9] requires an unmodified Met
sulfur. We believe that the role of this intact sulfur is not coordination of FeII but the
formation of sulfide radical cations as precursors for hydrolysis.
The formation of P2 is also prevented by (i) chelation of FeII with DTPA (instead of EDTA)
(Exp. 2, Figures 3 and 6C), (ii) replacing [FeII/EDTA]2– by [FeIII/EDTA]– (data not shown),
(iii) performing the reaction under Ar and chelation of FeII with DTPA prior to exposure of
the solution to air (Exp. 6, Figure 8A), and (iv) the addition of exogenous Met to the
solution. While P2 is not formed in the presence of [FeII/EDTA]2– under Ar (Figure 7B), P2
is formed when PTH(1-34) is exposed to air prior to the addition of DTPA (Figure 7A).
Based on all the experimental observations, we propose the mechanism detailed in Scheme
1. Complexation of [FeII(EDTA)]2– to His[9], followed by oxygen addition to FeII, leads to
a metal-bound peroxyl radical, C1. This peroxyl radical oxidizes the Met[8] sulfur via one-
electron transfer to yield C2 and a ferrous superoxo complex (reaction 14). While the
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possibility for back electron transfer exists, the intermediary sulfide radical cation will
complex with the peptide bond carbonyl function to form a cyclic, three-electron-bonded
intermediate C3 (equilibrium 15). Evidence for such cyclic sulfur–oxygen bonded
intermediates has been documented for various peptides by time-resolved spectroscopic
analysis during pulse radiolysis experiments.46,47 In intermediate C3, the complexation of
the carbonyl function by the positively charged sulfide radical cation can be compared to the
complexation of the peptide bond by other Lewis acids such as H+ or transition metals,
which leads to hydrolysis of the peptide bond.48–51 In fact, kinetic analysis of the stability of
sulfur–oxygen three-electron bonded intermediates in peptides have strongly suggested a
hydrolysis reaction52 analogous to that depicted in reaction 16. Subsequently, the remaining
sulfur radical cation I1 can be reduced back by the ferrous superoxo complex (reaction 17),
regenerating the initial FeII(Ln)OO• species.
The hydrolysis process in Scheme 1 is consistent with our experimental observation of O18
incorporation into product P2 (which results in the shift of its m/z 906.4–908.4, Figure 12)
when the oxidation reaction is performed in H2O18. Importantly, the hydrolysis cannot be
inhibited by the addition of CH3OH at sufficient concentrations to scavenge hydroxyl
radicals. This result is consistent with the mechanism in Scheme 1, which does not involve
hydroxyl radicals, and with the fact that O2, but not H2O2 (the precursor for hydroxyl
radicals) is required for the hydrolysis reaction. The necessity for an unoxidized Met residue
for hydrolysis is further indicated by our observation that (i) the replacement of Met[8] by
Ala[8], (ii) the oxidation of Met[8] to MetSO, and (iii) the addition of exogenous Met
prevented the hydrolysis reaction.
The hydrolysis mechanism observed under our experimental conditions is different from
those reported by Rana and Meares,53 where reaction between [FeIII(EDTA)]– and H2O2 led
to a nucleophile which attacked the peptide bond. Our mechanism clearly requires Met
oxidation and is directed via complexation of FeII to His[9] or Met[8]. From a
pharmaceutical viewpoint, the fact that the addition of EDTA cannot prevent the hydrolysis
is important, as EDTA is frequently used as a chelator to prevent metal-catalyzed reactions
in formulations.54 We did not observe the hydrolysis of the peptide bond between Met[8]
and His[9] in the presence of phosphate buffer. We did not investigate in detail the reason
why the hydrolysis did not occur in the presence of phosphate. Mechanistic evidence
suggests a complex formation between phosphate and sulfide radical cations, which may
interfere with equilibrium 15 and, consequently, with the hydrolysis reaction.55 We know
that phosphate can have a significant influence on the chemistry of sulfide radical cations.55
We tentatively rationalize the inhibition of hydrolysis by phosphate with the complexation
of the sulfide radical cation by phosphate.
Formation of Homocysteine
The formation of homocysteine proceeds under experimental conditions, which also
promote the hydrolysis between Met[8] and His[9], consistent with our hypothesis of a
common intermediate. In fact, the deprotonation of methionine radical cation C2 generates
two types of carbon-centered radicals, of which C5 represents a precursor for homocysteine
(reaction 18, Scheme 2).56 In the presence of air, C5 can react with O2 to form a peroxyl
radical, which ultimately leads to the formation of homocysteine (reactions 19–22, Scheme
2).
Oxidation of Met[8] and His[9]
After oxidation of PTH(1-34) in Ar at pH 6.9 and 7.8, and in accordance with the
experimental protocol Exp.5, we observed the oxidation of Met[8] and His[9] into MetSO
and 2-oxo-histidine, respectively. Changing the pH to pH 4.5 under otherwise similar
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conditions, led to complete conversion of Met[8] into MetSO (monitored through the ratio
P1/F5 = 100%). This result indicates that complexation of FeII by His is not necessary for
the oxidation of Met into MetSO by [FeII(EDTA)]2–/H2O2, consistent with earlier studies on
oxidation of Met-containing peptides, which did not contain His.16,31 The quantitation of the
oxidation yield of His[9] in wild type PTH was not possible since its oxidation was
accompanied by the oxidation of Met[8]. However, in the PTH mutant, the absence of
Met[8] allows for the quantitation of oxidation of His[9]. The conversion of His[9] into 2-
oxo-histidine in PTH-Met[8]/Ala[8] amounts to ca. 2%.
Oxidation of Met[18], W[23], and His[32]
Our results show that Met[18], W[23], and His[32] are not prone to significant oxidation
under our experimental conditions. While traces of their oxidation products are observed,
their yields are negligible in comparison to the yields of P1 and P2. In contrast, Ji et al.25
reported significant oxidation on Met[18] and W[23] during metal-catalyzed oxidation of
PTH for 24 h (at 40 °C) in air-saturated solutions containing FeCl2 and H2O2. We believe
that the differential sensitivity of Met[8] and Met[18] toward oxidation may be, in part,
caused by secondary structure. The NMR structures57 of PTH(1-34) show that Met[8] is
located in an α helix whereas Met[18] is not. Our theoretical and experimental studies58,59
have shown that a Met residue located within an α-helix can be more sensitive toward
oxidation as compared to a Met residue located outside an α-helix. This is due to the facile
complex formation between a sulfide radical cation and the peptide bond of the amino acid
residue in position i-4.
Significance
Frequently, EDTA is added to pharmaceutical formulations in an attempt to prevent peptide
and protein oxidation. The current results demonstrate that FeII/H2O2, [FeII(EDTA)]2–/
H2O2, FeII/O2, and [FeII(EDTA)]2–/O2 have the potential to oxidize Met and/or His in
PTH(1-34). Hence, these data provide evidence that the addition of EDTA may not always
protect a peptide or protein from oxidation. Importantly, Met sulfoxide is not the only
oxidation product of Met[8], which also converts to homocysteine. Moreover, both in the
absence and presence of EDTA, FeII catalyzes the site-specific cleavage of the peptide bond
between Met[8] and His[9], a mechanism likely depending on the intermediary formation of
a one-electron oxidized Met residue. We note that the FeII/FeIII concentrations used in our
experiments are significantly higher than those one would expect in pharmaceutical
formulations. Hence, the yield of hydrolysis/oxidation products under formulation
conditions can be expected to be lower. Our results further substantiate that FeIII, the iron
species pharmaceutical preparation most frequently encountered, will generate
predominantly methionine sulfoxide, not hydrolysis. However, FeII may be generated
through the reaction of FeIII with contaminating peroxides, providing a potential route to
hydrolysis. The question is whether the addition of EDTA can actually promote such
hydrolytic processes in larger proteins such as antibodies, for example through keeping FeII
(or FeIII) in solution.
5. CONCLUSION
Under relatively mild metal-catalyzed oxidation conditions, the oxidation of PTH(1-34) is
site-specific. Only Met[8] and His[9] are readily oxidized under conditions where all six
amino acid residues, Met[8], His[9], Met[18], Trp[23], His[32], and Phe[34] could have
been oxidized. A one-electron oxidized intermediate, a radical cation of Met[8] leads to a
selective hydrolytic cleavage between Met[8] and His[9]. We hypothesize that the particular
spatial conformation of Met[8] and His[9] renders this region sensitive to metal-catalyzed
oxidation and hydrolysis. The radical cation of Met[8] is likely at the origin of the
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transformation of Met[8] into homocysteine. However, the conversion of Met[8] into
homocysteine can be prevented by the addition of MeOH, without interfering with the
hydrolytic cleavage between Met[8] and His[9]. This result would suggest that HO• radicals
are involved in the transformation of Met[8] into homocysteine.
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Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We gratefully acknowledge Mary Cromwell's support of this project and financial support from Genentech, the
NIH (P01AG12993), and NSF (CHE-0956581).
REFERENCES
1. Cederbaum S, Vilain E. Defects in energy metabolism: coming of age, slowly. J. Pediatr. 2000;
136(2):147–8. [PubMed: 10657817]
2. Stadtman ER. Protein modification in aging. J. Gerontol. 1988; 43(5):B112–20. [PubMed: 3047204]
3. Ozben, T.; Chevion, M. Frontiers in Neurodegenerative Disorders and Aging: Fundamental Aspects,
Clinical Perspectives and New Insights. NATO Science Series ed.. IOS Press; Amsterdam: 2004.
4. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein
pharmaceuticals: an update. Pharm. Res. 2010; 27(4):544–575. [PubMed: 20143256]
5. Toennies G, Callan TP. Methionine studies: III. A comparison of oxidative reactions of methionine,
cysteine, and cystine. Determination of methionine by hydrogen peroxide oxidation. J. Biol. Chem.
1939; 129(2):481–490.
6. Cuq JL, Besancon P, Chartier L, Cheftel C. Oxidation of Methionine Residues of Food Proteins and
Nutritional Availability of Protein-Bound Methionine Sulfoxide. Food Chem. 1978; 3(2):85–102.
7. Cuq JL, Provansa M, Guilleux F, Cheftel C. Oxidation of Methionine Residues of Casein by
Hydrogen-Peroxide–Effects on in-Vitro Digestibility. J. Food Sci. 1973; 38(1):11–13.
8. Ellinger GM. Chemical Approach to Nutritional Availability of Methionine in Food Proteins. Ann.
Nutr. Aliment. 1978; 32(2−3):281–289. [PubMed: 707916]
9. Goldstein S, Meyerstein D, Czapski G. The Fenton reagents. Free Radical Biol. Med. 1993; 15(4):
435–445. [PubMed: 8225025]
10. Davies MJ. The oxidative environment and protein damage. Biochim. Biophys. Acta. 2005;
1703(2):93–109. [PubMed: 15680218]
11. Levine RL, Mosoni L, Berlett BS, Stadtman ER. Methionine residues as endogenous antioxidants
in proteins. Proc. Natl. Acad. Sci. U.S.A. 1996; 93(26):15036–15040. [PubMed: 8986759]
12. Zhao F, Ghezzo-Schöneich E, Aced GI, Hong JY, Milby T, Schöneich C. Metal-catalyzed
oxidation of histidine in human growth hormone - Mechanism, isotope effects, and inhibition by a
mild denaturing alcohol. J. Biol. Chem. 1997; 272(14):9019–9029. [PubMed: 9083026]
13. Levine RL. Oxidative Modification of Glutamine-Synthetase. 1. Inactivation Is Due to Loss of One
Histidine Residue. J. Biol. Chem. 1983; 258(19):1823–1827.
14. Li S, Nguyen TH, Schöneich C, Borchardt RT. Aggregation and precipitation of human relaxin
induced by metal-catalyzed oxidation. Biochemistry. 1995; 34(17):5762–5772. [PubMed:
7727437]
15. Lam XM, Lai WG, Chan EK, Ling V, Hsu CC. Site-Specific Tryptophan Oxidation Induced by
Autocatalytic Reaction of Polysorbate 20 in Protein Formulation. Pharm. Res. 2011; 28(10):2543–
2555. [PubMed: 21656082]
16. Hong J, Schöneich C. The metal-catalyzed oxidation of methionine in peptides by Fenton systems
involves two consecutive one-electron oxidation processes. Free Radical Biol. Med. 2001; 31(11):
1432–41. [PubMed: 11728815]
17. Torosantucci R, Mozziconacci O, Sharov V, Schöneich C, Jiskoot W. Chemical Modifications in
Aggregates of Recombinant Human Insulin Induced by Metal-Catalyzed Oxidation: Covalent
Mozziconacci et al. Page 16













Cross-Linking via Michael Addition to Tyrosine Oxidation Products. Pharm. Res. 2012; 29(8):
2276–2293. [PubMed: 22572797]
18. Rush JD, Koppenol WH. The reaction between ferrous polyaminocarboxylate complexes and
hydrogen peroxide: an investigation of the reaction intermediates by stopped flow
spectrophotometry. J. Inorg. Biochem. 1987; 29(3):199–215. [PubMed: 3106570]
19. Ikehata K, Duzhak TG, Galeva NA, Ji T, Koen YM, Hanzlik RP. Protein targets of reactive
metabolites of thiobenzamide in rat liver in vivo. Chem. Res. Toxicol. 2008; 21(7):1432–42.
[PubMed: 18547066]
20. Xu H, Freitas MA. MassMatrix: a database search program for rapid characterization of proteins
and peptides from tandem mass spectrometry data. Proteomics. 2009; 9(6):1548–55. [PubMed:
19235167]
21. Xu H, Freitas MA. A mass accuracy sensitive probability based scoring algorithm for database
searching of tandem mass spectrometry data. BMC Bioinform. 2007; 8:133.
22. Xu H, Yang L, Freitas MA. A robust linear regression based algorithm for automated evaluation of
peptide identifications from shotgun proteomics by use of reversed-phase liquid chromatography
retention time. BMC Bioinform. 2008; 9:347.
23. Xu H, Zhang L, Freitas MA. Identification and characterization of disulfide bonds in proteins and
peptides from tandem MS data by use of the MassMatrix MS/MS search engine. J. Proteome Res.
2008; 7(1):138–44. [PubMed: 18072732]
24. Khossravi M, Borchardt RT. Chemical pathways of peptide degradation: IX. Metal-catalyzed
oxidation of histidine in model peptides. Pharm. Res. 1998; 15(7):1096–1102. [PubMed: 9688066]
25. Ji JA, Zhang BY, Cheng W, Wang YJ. Methionine, Tryptophan, and Histidine Oxidation in a
Model Protein, PTH: Mechanisms and Stabilization. J. Pharm. Sci. 2009; 98(12):4485–4500.
[PubMed: 19455640]
26. Rush JD, Maskos Z, Koppenol WH. Distinction between hydroxyl radical and ferryl species.
Methods Enzymol. 1990; 186:148–156. [PubMed: 2172702]
27. Mizuta T, Wang J, Miyoshi K. A Seven-Coordinate Structure of Iron(II)−Ethylenediamine-N,N,N
′,N′-tetraacetato Complex as Determined by X-Ray Crystal Analysis. Bull. Chem. Soc. Jpn. 1993;
66(9):2547–2551.
28. Finnen DC, Pinkerton AA, Dunham WR, Sands RH, Funk MO. Structures and Spectroscopic
Characteristics of Iron(III) Diethylenetriaminepentaacetic Acid Complexes - a Nonheme Iron(III)
Complex with Relevance to the Iron Environment in Lipoxygenases. Inorg. Chem. 1991; 30(20):
3960–3964.
29. Ureno, K.; Imamura, T.; Chang, KL. CRC Handbook of Organic Analytical Reagents. CRC Press;
Boca Raton, FL: 1992.
30. Inczédy, J. Analytical Applications of Complex Equilibria. E. Horwood; Chichester, England:
1976.
31. Schöneich C, Yang J. Oxidation of methionine peptides by Fenton systems: the importance of
peptide sequence, neighboring groups and EDTA. J. Chem. Soc., Perkin Trans. 2. No. 1996;
5:915–924.
32. Rush JD, Koppenol WH. Oxidizing intermediates in the reaction of ferrous EDTA with hydrogen
peroxide. Reactions with organic molecules and ferrocytochrome c. J. Biol. Chem. 1986; 261(15):
6730–6733. [PubMed: 3009473]
33. Rahhal S, Richter HW. Reduction of hydrogen peroxide by the ferrous iron chelate of
diethylenetriamine-N,N,N′,N″,N″-pentaacetate. J. Am. Chem. Soc. 1988; 110(10):3126–3133.
34. Seibig S, van Eldik R. Kinetics of [FeII(edta)] Oxidation by Molecular Oxygen Revisited. New
Evidence for a Multistep Mechanism. Inorg. Chem. 1997; 36(18):4115–4120.
35. Meier R, Heinemann FW. Structures of the spontaneously resolved six-coordinate potassium
chloro-(ethylenediaminetriacetato acetic acid) iron(III) monohydrate and the seven-coordinate
potassium (ethylenediaminetetracetato) iron(III) sesquihydrate. Inorg. Chem. Acta. 2002;
337:317–327.
36. Brauer M, Benz FW. 1H NMR studies of the binding of EDTA to bovine pancreatic ribonuclease.
Biochim. Biophys. Acta. 1978; 533(1):186–94. [PubMed: 416852]
Mozziconacci et al. Page 17













37. Rush JD, Koppenol WH. Reactions of iron(II) nitrilotriacetate and iron(II) ethylenediamine-N,N′-
diacetate complexes with hydrogen peroxide. J. Am. Chem. Soc. 1988; 110(15):4957–4963.
38. Yamazaki I, Piette LH. EPR spin-trapping study on the oxidizing species formed in the reaction of
the ferrous ion with hydrogen peroxide. J. Am. Chem. Soc. 1991; 113(20):7588–7593.
39. Stumm W, Lee GF. Oxygenation of Ferrous Iron. Ind. Eng. Chem. 1961; 53(2):143–146.
40. Zang V, Vaneldik R. Kinetics and Mechanism of the Autoxidation of Iron(II) Induced through
Chelation by Ethylenediaminetetraacetate and Related Ligands. Inorg. Chem. 1990; 29(9):1705–
1711.
41. Sada E, Kumazawa H, Machida H. Oxidation-Kinetics of Fe-II-Edta and Fe-II-Nta Chelates by
Dissolved-Oxygen. Ind. Eng. Chem. Res. 1987; 26(7):1468–1472.
42. Bull C, Mcclune GJ, Fee JA. The Mechanism of Fe-Edta Catalyzed Superoxide Dismutation. J.
Am. Chem. Soc. 1983; 105(16):5290–5300.
43. Kurimura Y, Ochiai R, Matsuura N. Oxygen Oxidation of Ferrous Ions Induced by Chelation. Bull.
Chem. Soc. Jpn. 1968; 41(10):2234–2239.
44. Brown ER, Mazzarella JD. Mechanism of Oxidation of Ferrous Polydentate Complexes by
Dioxygen. J. Electroanal. Chem. 1987; 222(1−2):173–192.
45. Wubs HJ, Beenackers AACM. Kinetics of the oxidation of ferrous chelates of EDTA and HEDTA
in aqueous solution. Ind. Eng. Chem. Res. 1993; 32(11):2580–2594.
46. Schöneich C, Pogocki D, Hug G, Bobrowski K. Free radical reactions of methionine in peptides:
mechanisms relevant to beta-amyloid oxidation and Alzheimer's disease. J. Am. Chem. Soc. 2003;
125(45):13700–13. [PubMed: 14599209]
47. Schöneich C, Pogocki D, Wisniowski P, Hug GL, Bobrowski K. Intramolecular Sulfur−Oxygen
Bond Formation in Radical Cations of N-Acetylmethionine Amide. J. Am .Chem. Soc. 2000;
122(41):10224–10225.
48. Chin J. Developing artificial hydrolytic metalloenzymes by a unified mechanistic approach. Acc.
Chem. Res. 1991; 24(5):145–152.
49. Milović NM, Dutcǎ L-M, Kostić NM. Transition-Metal Complexes as Enzyme-Like Reagents for
Protein Cleavage: Complex cis-[Pt(en)(H2O)2]
2+ as a New Methionine-Specific Protease. Chem.–
Eur. J. 2003; 9(20):5097–5106. [PubMed: 14562327]
50. Milovic NM, Kostic NM. Interplay of terminal amino group and coordinating side chains in
directing regioselective cleavage of natural peptides and proteins with palladium(II) complexes.
Inorg. Chem. 2002; 41(26):7053–63. [PubMed: 12495344]
51. Milović NM, Kostić NM. Palladium(II) complexes, as synthetic peptidases, regioselectively cleave
the second peptide bond “upstream” from methionine and histidine side chains. J. Am. Chem. Soc.
2002; 124(17):4759–69. [PubMed: 11971725]
52. Bobrowski K, Hug GL, Pogocki D, Marciniak B, Schöneich C. Stabilization of Sulfide Radical
Cations through Complexation with the Peptide Bond: Mechanisms Relevant to Oxidation of
Proteins Containing Multiple Methionine Residues. J. Phys. Chem. B. 2007; 111(32):9608–9620.
[PubMed: 17658786]
53. Rana TM, Meares CF. Transfer of oxygen from an artificial protease to peptide carbon during
proteolysis. Proc. Natl. Acad. Sci. U.S.A. 1991; 88(23):10578–82. [PubMed: 1961724]
54. Zhou S, Zhang B, Sturm E, Teagarden DL, Schöneich C, Kolhe P, Lewis LM, Muralidhara BK,
Singh SK. Comparative Evaluation of Disodium Edetate and Diethylenetriaminepentaacetic Acid
as Iron Chelators to Prevent Metal-Catalyzed Destabilization of a Therapeutic Monoclonal
Antibody. J. Pharm. Sci. 2010; 99(10):4239–50. [PubMed: 20737631]
55. Schöneich C, Miller BL, Hug GL, Bobrowski K, Marciniak B. Intermolecular Complexes Between
Sulfide Radical Cations from β-Hydroxy Sulfides and Phosphate. Res. Chem. Intermed. 2001;
27(1,2):165–175.
56. Hiller KO, Masloch B, Göbl M, Asmus KD. Mechanism of the OH• Radical Induced Oxidation of
Methionine in Aqueous Solution. J. Am. Chem. Soc. 1981; 103(10):2734–2743.
57. Marx UC, Adermann K, Bayer P, Forssmann W-G, Rösch P. Solution Structures of Human
Parathyroid Hormone Fragments hPTH(1-34) and hPTH(1-39) and Bovine Parathyroid Hormone
Fragment bPTH(1-37). Biochem. Biophys. Res. Commun. 2000; 267(1):213–220. [PubMed:
10623601]
Mozziconacci et al. Page 18













58. Pogocki D, Schöneich C. Redox Properties of Met(35) in Neurotoxic Beta-Amyloid Peptide. A
Molecular Modeling Study. Chem. Res. Toxicol. 2002; 15(3):408–18. [PubMed: 11896689]
59. Kanski J, Aksenova M, Schoneich C, Butterfield DA. Substitution of Isoleucine-31 by Helical-
Breaking Proline Abolishes Oxidative Stress and Neurotoxic Properties of Alzheimer's Amyloid
Beta-Peptide. Free Radical Biol. Med. 2002; 32(11):1205–1211. [PubMed: 12031904]
Mozziconacci et al. Page 19














Representation of the sequences of human parathyroid hormones (PTH(1-34) and
PTH(1-34) Met[8]Ala mutant). The dashed lines indicate the digestion sites obtained by
means of trypsin in ammonium bicarbonate buffer (50 mM, pH 8). The tryptic fragments are
noted as F1–F5.
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Schematic representation of the processes used to oxidize and digest PTH(1-34). Pathways a
and b describe processes performed under air and Ar, respectively.
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Percentage of conversion of the tryptic fragment F5 into products P1 and P2 after oxidation
of PTH(1-34) under the experimental conditions Exp. 1–6 as described in Section 2.2 and
schematized in Figure 2. The bars indicate the lowest and highest ratios of transformation of
F5 into P1 and P2 over five replicates.
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CID mass spectrum obtained by means of a SYNAPT mass spectrometer of product P1 (m/z
736.4, doubly charged) generated after oxidation of PTH(1-34).
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CID mass spectrum obtained by means of a SYNAPT mass spectrometer of product P2 (m/z
906.4) generated after oxidation of PTH(1-34).
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LC-MS analysis of oxidized PTH(1-34) (24.3 μM) in air: (A) control, no oxidation; (B)
oxidation in the presence of [FeII/EDTA]2– (100 μM) and H2O2 (100 μM); DTPA (500
μM) was added to the solution prior to digestion; (C) oxidation in the presence of FeII and
DTPA (100 μM); H2O2 (100 μM) and DTPA (500 μM) were added to the solution prior to
digestion; (D) oxidation in the presence of [FeII/EDTA]2– (100 μM) and H2O2 (100 μM);
(E) oxidation in the presence of [FeII/EDTA]2– (100 μM); DTPA (500 μM) was added to
the solution prior to digestion. In all cases catalase (0.07 μM) was added to the solution
prior the digestion.
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LC-MS analysis of oxidized PTH(1-34) (24.3 μM) under Ar in the presence of [FeII/
EDTA]2– (100 μM) and H2O2 (100 μM): (A) no DTPA was added prior to open the tube to
air; (B) DTPA (500 μM) was added in the solution prior exposure of the solution to air and
LC-MS analysis. In all the case catalase (0.07 μM) was added under Ar.
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LC-MS analysis of oxidized PTH(1-34) (24.3 μM): (A) PTH(1-34) preoxidized with H2O2
was exposed to [FeII/EDTA]2– (100 μM) and H2O2 (100 μM) under Ar. Catalase (0.07 μM)
was added to the solution prior to the digestion, (B) control.
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LC-MS analysis of oxidized PTH(1-34) (24.3 μM) under Ar in the presence of DTPA (100
μM) and H2O2 (100 μM). Catalase (0.07 μM) was added under Ar.
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LC-MS analysis of oxidized PTH(1-34) (24.3 μM) by H2O2 and following by Fenton
oxidation according to the experimental protocol Exp. 1.
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LC-MS analysis of oxidized PTH(1-34) (24.3 μM) and PTH(1-34) Met[8]Ala (24.6 μM)
under air: (A) oxidation of PTH(1-34) in the presence of [FeII/EDTA]2– (100 μM), H2O2
(100 μM); DTPA (500 μM) was added to the solution prior to digestion. The chromatogram
highlights product P2. (B) Control of nonoxidized PTH(1-34) Met[8]Ala. The MS/MS
spectrum of the tryptic fragment F5A is presented in Figure S10 (Supporting Information).
(C) Oxidation of PTH(1-34) Met[8]Ala in the presence of [FeII/EDTA]2– (100 μM), H2O2
(100 μM); DTPA (500 μM) was added to the solution prior to digestion. (D) oxidation of
PTH(1-34) Met[8]Ala in the presence of [FeII/EDTA]2– (100 μM), H2O2 (100 μM), DTPA
(500 μM) was added in the solution prior to digestion. Chromatogram D shows the absence
of P2A (m/z 846.4). The absolute intensity for the most abundant species is displayed in
each chromatogram.
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Oxidation of PTH(1-34) in the presence of H2O18/H2O16 (80:20, v:v). Mass spectrum in the
range of the m/z of product P2 (m/z 906.4, when generated in the presence of 100% H2O16).
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CID mass spectrum obtained by means of a FT-ICR mass spectrometer of product P4 (m/z
721.4, doubly charged) generated after oxidation of PTH(1-34). X stands for the
homocysteine residue.
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CID mass spectrum obtained by means of a FT-ICR mass spectrometer of product P4-NEM
(m/z 721.4, doubly charged) generated after oxidation of PTH(1-34). “u1” and “u2” stand for
the homocysteine and C-terminal lysine residues derivatized with NEM, respectively.
Mozziconacci et al. Page 33














Postulated Reaction Mechanism to Rationalize the Formation of P2 during Oxidation of
PTH(1-34) by [FeII(Ln)]m– and Oxygen. (Ln = EDTA, H2O, or Acetate). R1 and R2
Represent the Peptide Sequences SVSEIQL and NLGKHLNSMERVEWLRKKLQDVHNF,
Respectively
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Postulated Reaction Mechanism to Rationalize the Transformation of Met[8] into
Homocysteine during Oxidation of PTH(1-34). R1 and R2 Represent the Peptide Sequences
SVSEIQL and HNLGKHLNSMERVEWLRKKLQDVHNF, Respectively
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Table 1
Summary of the PTH(1-34) and PTH(1-34) Met[8]Ala Mutant Tryptic Fragments and Products of Oxidation
reference sequence
a MS/MS spectrum
F1 HLNSMER Figure S1
F2 KLQDVHNF Figure S2
F3 LQDVHNF Figure S3
F4 VEWLR Figure S4
F5 SVSEIQLMHNLGK Figure S5
F5A SVSEIQLAHNLGK Figure S10
P1 SVSEIQLMoxHNLGK Figure 4
P2 SVSEIQLM Figure 5
P3 SVSEIQLMoxHoxNLGK Figure S6
P4 SVSEIQL(Hcys)HNLGK Figure 13
P2A SVSEIQLA not observed
a
Mox and Hox stand for methionine sulfoxide and 2-oxo-histidine, respectively. In product P4, Hcys represents homocysteine.
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Table 2
Summary of the Major Results Observed under the Different Conditions of Oxidation
experimental protocol major observations
Exp. 1 formation of P1 and P2. See Figure 6B
Exp. 2 formation of P1 only. See Figure 6C
Exp. 3 formation of P1 and P2. See Figure 6
Exp. 4 formation of P1 with much lower yield than those observed in previous protocols. Increase of
the yield of P2. See Figure 6E
Exp. 5 formation of P1 and P2. See Figure 7A
Exp. 6 formation of P1 only. See Figure 7B
Exp. 7 complete oxidation of Met[8] into MetSO (P1). P2 is not formed. See Figure 8A
Exp. 8 formation of P1 only
Exp. 9 formation of P1 with a lower yield than those observed in previous protocols. P2 is observed
with a yield similar to that calculated in Exp. 1 and 3
Exp. 10 (1) Mass spectrometry analysis of full PTH (no digestion). (2) Fenton oxidation run in the
presence of H2O18. Incorporation of O18 is observed in product P2. See Figure 12
Exp. 1 with PTH mutant (Met[8] was replaced
by Ala[8])
absence of the hydrolytic cleavage between Ala[8] and His[9]. See Figure 11D
Exp. 1 and excess of exogenous Met formation of P2 is prevented
Preoxidation of Met residues to MetSO and
His to 2-oxo-histidine prior to apply the
experimental protocol Exp. 1
formation of P2 is prevented
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